Skip to content
Recall Observatory FDA recall evidence

Drug product

Imatinib Mesylate Tablets 400 mg, Rx Only, 30-count Bottle, Manufactured by: Shilpa Medicare Limited, India, Distributed by: Armas Pharmaceuticals Inc., Manalapan, NJ 07726, NDC 72485-203-30.

D-0125-2021

December 08, 2020

Class II

Product summary

Firm
Shilpa Medicare Limited
Event
Event 86749
Status
Terminated
Classification
Class II
Quantity
4166 bottles
Official record key
drug-enforcement:D-0125-2021

Official wording

Reason: CGMP Deviations

Code information: Lot #s: 7S10032A, 7S10034A, Exp. 02/28/2021

Distribution pattern: Nationwide in the U.S.

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations